F. Jarreau

发表

Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.

J. Wouters, D. P. Vercauteren, F. Durant, 1994, Journal of neural transmission. Supplementum.

Structural and theoretical study of 5-(R)-(methoxymethyl)-3-aryl-oxazolidin-2-ones, reversible monoamine oxidase inhibitors

J. Wouters, F. Durant, M. Dőry, 1993 .

A reversible monoamine oxidase inhibitor, toloxatone: structural and electronic properties

J. Wouters, D. P. Vercauteren, F. Durant, 1992 .

THE DRAMBALLET STUDIO

O. Curet, V. Rovei, N. Sontag, 1996 .

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.

O. Curet, V. Rovei, N. Sontag, 1996, The Journal of pharmacology and experimental therapeutics.

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.

O. Bergis, C. Fankhauser, A. Grosset, 1996, The Journal of pharmacology and experimental therapeutics.

A reversible monoamine oxidase inhibitor, Toloxatone: comparison of its physicochemical properties with those of other inhibitors including Brofaromine, Harmine, R40519 and Moclobemide

J. Wouters, D. P. Vercauteren, F. Durant, 1995 .

A reversible monoamine oxidase inhibitor, toloxatone: spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD)

J. Wouters, D. P. Vercauteren, F. Durant, 1994 .

COMPARATIVE HEMODYNAMIC STUDY OF A NEW AMINOSTEROID: LND‐623 WITH ITS 20α‐ISOMER: LND‐369, AND WITH DIGOXIN AND DIGOXIGENIN‐RHAMNOSIDE IN THE ANESTHETIZED DOG

G. Cheymol, J. Poirier, P. Jaillon, 1989, Fundamental & clinical pharmacology.

Carbon-13 NMR analysis of cyclic peptide alkaloids

E. Hagaman, E. Rúveda, M. Sierra, 1979 .

Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor.

O. Curet, V. Rovei, D. Caille, 1994, Journal of neural transmission. Supplementum.

Steroid alkaloids CLXX (1). Backbone rearrangement XV (2). On the 1,2 hydride shifts.

J. Thierry, F. Frappier, F. Jarreau, 1974 .

[Apropos of a falsification of Strophantus gratus Franchet seeds. A new alkaloid, alafine, isolated from Alafia sp. seeds and from Alafia multiflora Stapf (Apocynaceae)].

P. Fouché, F. Jarreau, M. Païs, 1971, Annales pharmaceutiques francaises.

Further confirmation of the presence of indolylacrylic acid in lentil seedlings and identification of hypaphorine as its precursor

M. Hofinger, M. Pais, F. Jarreau, 1975 .

Growth and digoxin content in Digitalis lanata in controlled conditions and natural environment.

C. Brugidou, L. Cosson, F. Jarreau, 1988, Planta medica.

A new peptide alkaloid from Discaria crenata

D. S. Bhakuni, Mario Silva, F. Jarreau, 1974 .